Men's Health News

RSS

BHR to demonstrate EKF Quo-Test HbA1c analyser at Heart UK's conference

EKF, announces today that the Quo-Test, its glycated haemoglobin analyser for near-patient monitoring of diabetes will be on show at Heart UK.

From EKF Diagnostics 2 Jul 2013

Low doses of arsenic and estrogen can cause cancer in prostate cells, study finds

Science knows that arsenic and estrogen can cause cancer. At certain very low levels, the chemicals offer little to no threats to human health.

29 Jun 2013

Scientists find high prevalence of HPV infection in oral, anal and penile cavities in HIV-positive men

Scientists in Barcelona have found a high presence of papillomavirus infection in oral, anal and penile cavities in HIV-positive men, particularly in the anal cavities of men who have homosexual sex. The researchers recommend routine examination of the three areas in all men, independently of their sexual behaviour.

27 Jun 2013

Sleep apnea severity higher among African-American men, WSU researcher finds

A Wayne State University researcher has found that sleep apnea severity is higher among African-American men in certain age ranges, even after controlling for body mass index.

27 Jun 2013

Study: Active surveillance does not appear to be good idea for black men with prostate cancer

A Johns Hopkins study of more than 1,800 men ages 52 to 62 suggests that African-Americans diagnosed with very-low-risk prostate cancers are much more likely than white men to actually have aggressive disease that goes unrecognized with current diagnostic approaches.

26 Jun 2013

Study examines increased use of new technologies for prostate cancer treatment

Use of advanced treatment technologies for prostate cancer, such as intensity-modulated radiotherapy and robotic prostatectomy, has increased among men with low-risk disease, high risk of noncancer mortality, or both, a population of patients who are unlikely to benefit from these treatments, according to a study in the June 26 issue of JAMA.

26 Jun 2013

Research paper reveals Cav-1 protein's role in prostate tumor microenvironment

Researchers at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute have uncovered for the first time the vital role a popular protein plays in the stroma, the cell-lined area outside of a prostate tumor.

26 Jun 2013

EC grants marketing authorization for XTANDI capsules for treating advanced prostate cancer

Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. announced that following the regulatory review process by the European Medicines Agency (EMA) and a positive opinion from the Committee for Medicinal Products for Human Use on April 25, 2013, the European Commission (EC) has granted the marketing authorization for XTANDI™ (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.

24 Jun 2013

Researchers develop method to identify aggressive prostate cancers

Researchers at Moffitt Cancer Center and colleagues at Louisiana State University have developed a method for identifying aggressive prostate cancers that require immediate therapy. It relies on understanding the genetic interaction between single nucleotide polymorphisms. The goal is to better predict a prostate cancer's aggressiveness to avoid unnecessary radical treatment.

20 Jun 2013

Exposing tissue to low levels of BPA linked to greater incidence of prostate cancer

Exposing developing tissue to low levels of the plastic bisphenol A, commonly known as BPA, is linked to a greater incidence of prostate cancer in tissue grown from human prostate stem cells, a new study finds. The results were presented Monday, June 17, at The Endocrine Society's 95th Annual Meeting in San Francisco.

19 Jun 2013

Combination of obesity and low testosterone increases risk of diabetes and brain damage

Low testosterone worsens the harmful effects of obesity in the nervous system, a new study in mice finds. The results will be presented Monday at The Endocrine Society's 95th Annual Meeting in San Francisco.

18 Jun 2013

Men with haplogroup I of Y chromosome have 50% greater risk of developing heart disease

University of Leicester scientists have discovered a potential genetic contributor to the increased risk of heart disease among men.

18 Jun 2013

Early exposure to BPA increases risk for prostate cancer in human prostate tissue

Early exposure to BPA (bisphenol A) - an additive commonly found in plastic water bottles and soup can liners - causes an increased cancer risk in an animal model of human prostate cancer, according to University of Illinois at Chicago researcher Gail Prins.

18 Jun 2013

Pyrvinium pamoate inhibits drug-resistant prostate cancer

A new drug called pyrvinium pamoate inhibits aggressive forms of prostate cancer that are resistant to standard drugs, according to a study conducted in an animal model. The results will be presented Monday at The Endocrine Society's 95th Annual Meeting in San Francisco.

18 Jun 2013

Men with low-risk prostate cancers can choose watchful waiting for better quality of life, study says

Many men with low-risk, localized prostate cancers can safely choose active surveillance or "watchful waiting" instead of undergoing immediate treatment and have better quality of life while reducing health care costs, according to a study by researchers at Dana-Farber Cancer Institute and Massachusetts General Hospital.

18 Jun 2013

Google to feature health-centered Google+ Hangouts for International Men's Health Month

Google, in partnership with WireBuzz.com and Prevention.com, will feature a series of health-centered Google+ Hangouts for International Men's Health Month. The live discussions will build awareness around men's health issues including diet and exercise, cancer, sexual health and more.

15 Jun 2013

IPC to distribute AP's Promescent in US for treatment of premature ejaculation

The Independent Pharmacy Cooperative and Absorption Pharmaceuticals have signed a distribution agreement whereby IPC will make AP's topical treatment for premature ejaculation, Promescent, available to its 4,500+ member pharmacies throughout the United States.

14 Jun 2013

Men's Health News

BHR to demonstrate EKF Quo-Test HbA1c analyser at Heart UK's conference

Low doses of arsenic and estrogen can cause cancer in prostate cells, study finds

Scientists find high prevalence of HPV infection in oral, anal and penile cavities in HIV-positive men

Sleep apnea severity higher among African-American men, WSU researcher finds

Study: Active surveillance does not appear to be good idea for black men with prostate cancer

Study examines increased use of new technologies for prostate cancer treatment

Research paper reveals Cav-1 protein's role in prostate tumor microenvironment

EC grants marketing authorization for XTANDI capsules for treating advanced prostate cancer

Researchers develop method to identify aggressive prostate cancers

Exposing tissue to low levels of BPA linked to greater incidence of prostate cancer

Combination of obesity and low testosterone increases risk of diabetes and brain damage

Men with haplogroup I of Y chromosome have 50% greater risk of developing heart disease

Early exposure to BPA increases risk for prostate cancer in human prostate tissue

Pyrvinium pamoate inhibits drug-resistant prostate cancer

Men with low-risk prostate cancers can choose watchful waiting for better quality of life, study says

Google to feature health-centered Google+ Hangouts for International Men's Health Month

IPC to distribute AP's Promescent in US for treatment of premature ejaculation

Study: Stress felt by dad leaves lasting impression on his sperm

Esophageal cancer: A serious threat to African-American men

Research reveals that men who experience RLS may have higher risk of dying earlier

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Latest News